INPLASY202420024

Efficacy and Safety of Neoadjuvant, Adjuvant, and Perioperative Immune Checkpoint Inhibitors Single Agent or with Chemotherapy in Resectable NSCLC: Indirect Comparison and Clinicopathological Impact

Keywords: Neoadjuvant; perioperative; adjuvant; immune checkpoint inhibitor; Non-small cell lung cancer.

Download PDF - 202420024

Review Status: Ongoing